Sinopharm
1099.HK
#2681
Rank
A$9.59 B
Marketcap
A$3.07
Share price
1.89%
Change (1 day)
-14.61%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: A$3.52 Billion

According to Sinopharm's latest financial reports the company's current earnings are A$82.21 Billion. In 2025 the company made an earning of A$3.52 Billion, an increase over its 2024 earnings that were of A$3.30 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025A$3.52 B6.59%
2024A$3.30 B-27.86%
2023A$4.57 B-0.73%
2022A$4.61 B-1.72%
2021A$4.69 B11.7%
2020A$4.20 B18.44%
2019A$3.54 B10.85%
2018A$3.19 B3.05%
2017A$3.10 B36.48%
2016A$2.27 B7.11%
2015A$2.12 B12.38%
2014A$1.89 B25.05%
2013A$1.51 B22.54%
2012A$1.23 B35.43%
2011A$0.91 B52.24%
2010A$0.59 B30.99%
2009A$0.45 B60.59%
2008A$0.28 B48.29%
2007A$0.19 B123.29%
2006A$85.89 M